1
Jeffrey O Phillips: Substituted benzimidazole dosage forms and method of using same. Curators of the University of Missouri, Joseph A Mahoney, Thomas R Stiebel, Mayer Brown Rowe & Maw, November 11, 2003: US06645988 (79 worldwide citation)

The present invention relates to pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors. There is provided a liquid or solid pharmaceutical dosage form that is not enteric coated or delayed released containing a proton pump inhibitor and a Primary Essential Buffer. W ...


2
Jeffrey Owen Phillips: Substituted benzimidazole dosage forms and method of using same. The Curators of the University of Missouri, Joseph A Mahoney, Thomas R Stiebel, Mayer Brown Rowe & Maw, December 3, 2002: US06489346 (63 worldwide citation)

There is provided a solid pharmaceutical composition in a dosage form that is not enteric-coated, having active ingredients including a non-enteric coated proton pump inhibitor and at least one buffering agent. The proton pump inhibitor is omeprazole, lansoprazole, rabeprazole, esomeprazole, pantopr ...


3
Jeffrey O Phillips: Substituted benzimidazole dosage forms and method of using same. The Curators of the University of Missouri, Joseph A Mohoney, Mayer Brown Rowe & Maw, August 24, 2004: US06780882 (36 worldwide citation)

There is provided a solid pharmaceutical composition having active ingredients that include at least one non-enteric coated proton pump inhibitor and at least one buffering agent. The proton pump inhibitor, for example, omeprazole, lansoprazole, rabeprazole, esomeprazole, pantoprazole, pariprazole, ...


4
Jeffrey Owen Phillips: Substituted benzimidazole dosage forms and method of using same. Curators of the University of Missouri, Mayer Brown, July 15, 2008: US07399772 (30 worldwide citation)

The present invention relates to pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors. There is provided a liquid or solid pharmaceutical composition consisting of a proton pump inhibitor and at least one buffering agent. Also provided is a pharmaceutical compositi ...


5
Phillips Jeffrey O: Novel substituted benzimidazole dosage forms and method of using same. Univ Missouri, June 4, 2008: EP1927354-A1

A solid oral pharmaceutical composition, comprising: a) a proton pump inhibitor; and b) at least one buffering agent; wherein said composition is in a dosage form selected from the group consisting of a powder, a tablet, a suspension tablet, a chewable tablet, a capsule, an effervescent powder, an e ...


6
PHILLIPS JEFFREY O: [fr] Nouvelles formes posologiques comprenant des benzimidazoles substitués et des méthodes pour leur administration, [de] Neue Darreichungsformen für substituierte Benzimidazole und Methoden zu deren Anwendung, [en] Novel substituted benzimidazole dosage forms and method of using same. UNIV MISSOURI, April 6, 2011: EP2305259-A1

[en] The invention provides a solid oral pharmaceutical composition in capsule or powder dosage form comprising: a) omeprazole or a single enantiomer thereof, including a salt or other derivative thereof and b) sodium bicarbonate wherein the dosage form is not enteric coated or time-released, and th ...


7
Phillips Jeffrey O: Novel substituted benzimidazole dosage forms and method of using same. Univ Missouri, June 23, 2004: EP1430895-A1

The invention concerns a solid pharmaceutical dosage form capable of direct oral administration to a subject comprising at least one proton pump inhibitor in an amount of about 2 mg to about 300 mg; at least one buffering agent; and optionally one or more pharmaceutically acceptable excipients; and ...


8
Phillips Jeffrey O: Novel substituted benzimidazole dosage forms and method of using same. Univ Missouri, May 6, 2004: EP1414452-A1

The present invention relates to pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors. There is provided a liquid or solid pharmaceutical dosage form that is not enteric coated or delayed released containing a proton pump inhibitor and a Primary Essential Buffer, a ...


9
Phillips Jeffrey O: Novel substituted benzimidazole dosage forms and method of using same. Univ Missouri, October 9, 2002: EP1246622-A1

New pharmaceutical composition comprising a PPI and a buffering agent in treating gastric acid disorders.


10